The product combines two of the most popular OTC pain medications to provide up to 12 hours of pain relief
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | FDA approves first OTC combo of Tylenol and Naproxen for 'non-opioid' pain relief | 0 | 10.33 | 29-07-2026 |
| 2 | What is the new FDA-approved pill designed to slash cholesterol levels? | 0 | 5 | 17-07-2026 |
| 3 | New Pivotal Study Data Released for Takeda’s Oveporexton | 5 | 7 | 16-06-2026 |
| 4 | Granules secures FTF status for CNS depressant generic | 2 | 3 | 06-07-2026 |
| 5 | Health Canada Approves Zepbound for OSA in Adults With Obesity | 5 | 8 | 25-06-2026 |
| 6 | Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days | 0 | 5 | 31-07-2025 |
| 7 | Пресс-конференция о первом российском препарате от коронавируса. Видеотрансляция | 0 | 0 | 01-06-2020 |
| 8 | Trump administration proposes a rule it says could save Medicare patients $1.1 billion on drugs | 0 | 5 | 02-07-2026 |
| 9 | Court to consider thorny dispute between manufacturers of medication and its generic substitute | 0 | 5 | 24-04-2026 |
| 10 | Российский препарат для лечения от коронавируса "Авифавир" получил одобрение Минздрава | 0 | 0 | 30-05-2020 |